Robot surgery vs. traditional: which prostate cancer treatment costs less?
NCT ID NCT01577836
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the total cost of two types of prostate cancer surgery over 5 years: robot-assisted surgery using the da Vinci system and traditional open surgery. Researchers tracked medical expenses and patient outcomes in 90 men with localized prostate cancer. The goal was to see which approach is more cost-effective without directly testing a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHM - Hôpital de la Conception
Marseille, 13385, France
-
CHU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
-
Clinique Beau Soleil
Montpellier, 34070, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug deliver a toxic payload to prostate cancer cells?
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- Hormone therapy showdown: can an oral pill beat the shot for prostate cancer patients?
- Can a new daily pill slow advanced prostate cancer?
- Immunotherapy combo takes on Hard-to-Treat prostate cancer
- Could a targeted drug delay prostate cancer progression?